Medley is taking shape at the corner of McGinnis Ferry Road and Johns Creek Parkway. Along with office space, it will have ...

The richest new heir this year is Marilyn Simons, the widow of hedge fund mogul Jim Simons. She is now credited with an ...

Boehringer Ingelheim subsidiary NBE Therapeutics has opened its new antibody-drug conjugates (ADC) research and development ...

Boehringer Ingelheim, a biopharmaceutical firm that manufactures medicine for humans and animals, has relocated to a ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

Johannes von Baumbach, along with three of his older siblings who are aged 23, 25, and 27 are now worth an estimated $5.4 billion each.

The Dietary Guidelines for America are due by the end of the year, but Trump administration statements raise doubts as to ...

The idea of direct-to-patient channels in pharma conjures up services like Lilly Direct and PfizerForAll. But ...

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...

Historical trends and future projections of the number of people with overweight and obesity suggest alarming parallel ...

Several pharma CEOs met with Chinese President Xi Jinping in Beijing. President Donald Trump's reciprocal tariffs have mostly ...

Ferric carboxymaltose, an IV iron replacement therapy, did not reduce the time to first HF hospitalization or CV death for patients with HF and iron deficiency, according to results of a late-breaking ...